GB202202628D0 - Novel use and method comprising IL-2 and a tissue- or organic-specific targeting moiety - Google Patents
Novel use and method comprising IL-2 and a tissue- or organic-specific targeting moietyInfo
- Publication number
- GB202202628D0 GB202202628D0 GBGB2202628.0A GB202202628A GB202202628D0 GB 202202628 D0 GB202202628 D0 GB 202202628D0 GB 202202628 A GB202202628 A GB 202202628A GB 202202628 D0 GB202202628 D0 GB 202202628D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- tissue
- organic
- targeting moiety
- specific targeting
- novel use
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A61K38/2013—IL-2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14141—Use of virus, viral particle or viral elements as a vector
- C12N2750/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurosurgery (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Neurology (AREA)
- Hospice & Palliative Care (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB2202628.0A GB202202628D0 (en) | 2022-02-25 | 2022-02-25 | Novel use and method comprising IL-2 and a tissue- or organic-specific targeting moiety |
PCT/GB2023/050424 WO2023161648A1 (en) | 2022-02-25 | 2023-02-24 | Novel use and method comprising il-2 and a tissue- or organ-specific targeting moiety |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB2202628.0A GB202202628D0 (en) | 2022-02-25 | 2022-02-25 | Novel use and method comprising IL-2 and a tissue- or organic-specific targeting moiety |
Publications (1)
Publication Number | Publication Date |
---|---|
GB202202628D0 true GB202202628D0 (en) | 2022-04-13 |
Family
ID=81075481
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB2202628.0A Ceased GB202202628D0 (en) | 2022-02-25 | 2022-02-25 | Novel use and method comprising IL-2 and a tissue- or organic-specific targeting moiety |
Country Status (2)
Country | Link |
---|---|
GB (1) | GB202202628D0 (en) |
WO (1) | WO2023161648A1 (en) |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1290206A2 (en) * | 2000-06-09 | 2003-03-12 | University of Florida | Recombinant aav vectors for gene therapy of obesity |
JP2005514403A (en) * | 2001-12-21 | 2005-05-19 | ザ ソーク インスティテュート フォー バイオロジカル スタディーズ | Targeted retrograde gene delivery to motor neurons |
WO2013123503A1 (en) * | 2012-02-17 | 2013-08-22 | The Children's Hospital Of Philadelphia | Aav vector compositions and methods for gene transfer to cells, organs and tissues |
US20190038774A1 (en) * | 2015-01-26 | 2019-02-07 | The Research Institute At Nationwide Children's Hospital | Compounds, compositions, and methods for using hla-f |
JP7403165B2 (en) * | 2017-12-19 | 2023-12-22 | ザ・ユニヴァーシティ・オヴ・ノース・キャロライナ・アト・チャペル・ヒル | Methods and compositions for delivering viral vectors across the blood-brain barrier |
GB201912863D0 (en) | 2019-09-06 | 2019-10-23 | Babraham Inst | Novel method |
EP4076429A4 (en) * | 2019-12-16 | 2024-01-31 | Univ California | Compositions and methods for treating neuromuscular disorders |
-
2022
- 2022-02-25 GB GBGB2202628.0A patent/GB202202628D0/en not_active Ceased
-
2023
- 2023-02-24 WO PCT/GB2023/050424 patent/WO2023161648A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
WO2023161648A1 (en) | 2023-08-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP4004026A4 (en) | Il-2 cytokine prodrugs comprising a cleavable linker | |
GB202202628D0 (en) | Novel use and method comprising IL-2 and a tissue- or organic-specific targeting moiety | |
EP4061254A4 (en) | Targeting guides | |
GB202118073D0 (en) | Novel method and composition comprising IL-2 and a tissue- or organ-specific targeting moiety | |
GB202306163D0 (en) | Use and method | |
EP4132666A4 (en) | A game apparatus | |
GB202307777D0 (en) | Method and kit-of-parts | |
GB202302887D0 (en) | Rna | |
CA208261S (en) | Handheld stress relief toy | |
GB202006975D0 (en) | A method and apparatus for RNA synthesis | |
AU2020901657A0 (en) | A game apparatus | |
GB202215847D0 (en) | Part of a protective apparatus and protective apparatus | |
GB202019563D0 (en) | Appratus and method | |
AU2024901357A0 (en) | Training Aid | |
AU2022901873A0 (en) | Gel blaster accessory | |
AU2022902252A0 (en) | Total Fencer | |
GB202306380D0 (en) | Ball-sport training aid | |
ZA202302220B (en) | A convenient book placement platform | |
GB202201808D0 (en) | Training aid | |
GB202314732D0 (en) | A hair apparatus | |
GB202301186D0 (en) | A flexible and protective wrap for structures | |
GB202318692D0 (en) | An adjustable spacer and a method of using the same | |
GB202312078D0 (en) | Use and method | |
GB202310225D0 (en) | Method and use | |
AU2023902379A0 (en) | RNA vaccines |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |